BBP Among Health Care ETFs
End-of-day Nov 17, 2026 · 39 Health care ETFs by 1M
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −0.7% | −4.9% | −3.6% | −10.2% | +23.5% | +29.0% | +110.1% | +91.9% | +228.5% | +284.5% |
| Peer average | −1.2% | −4.0% | +2.1% | −3.2% | +18.2% | +23.3% | +71.2% | +24.1% | +174.3% | — |
| S&P 500 · VOO | −1.0% | −2.4% | −4.5% | −4.5% | +8.3% | +10.2% | +72.7% | +68.0% | +305.1% | — |
$59 of every $1,000 in BBP is Moderna
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | MRNAModerna | Healthcare | 5.85% | $585.43 | 35K | $7.6M |
| 2 | XERSXeris Biopharma | Healthcare | 3.34% | $333.83 | 258K | $4.3M |
| 3 | OMEROmeros | Healthcare | 2.59% | $259.19 | 201K | $3.3M |
| 4 | VSTMVerastem | Healthcare | 2.55% | $254.91 | 428K | $3.3M |
| 5 | IOVAIovance Biotherapeutics | Healthcare | 2.51% | $251.17 | 430K | $3.2M |
| 6 | KNSAKiniksa Pharmaceuticals International | Healthcare | 2.46% | $246.49 | 34K | $3.2M |
| 7 | ADMAADMA Biologics | Healthcare | 2.23% | $222.69 | 214K | $2.9M |
| 8 | REGNRegeneron Pharmaceuticals | Healthcare | 2.11% | $211.12 | 2,863 | $2.7M |
| 9 | BGNEBeOne Medicines | — | 2.11% | $211.06 | 6,628 | $2.7M |
| 10 | HALOHalozyme Therapeutics | Healthcare | 1.88% | $188.46 | 25K | $2.4M |
| 11 | ZLABZai Lab | Healthcare | 1.87% | $186.62 | 103K | $2.4M |
| 12 | GILDGilead Sciences | Healthcare | 1.81% | $181.10 | 14K | $2.3M |
| 13 | RIGLRigel Pharmaceuticals | Healthcare | 1.81% | $180.69 | 53K | $2.3M |
| 14 | IRWDIronwood Pharmaceuticals | — | 1.80% | $180.36 | 480K | $2.3M |
| 15 | AMGNAmgen | Healthcare | 1.77% | $176.65 | 4,935 | $2.3M |
of the $112B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | MRNA | Moderna | 5.85% |
| 2 | XERS | Xeris Biopharma | 3.34% |
| 3 | OMER | Omeros | 2.59% |
| 4 | VSTM | Verastem | 2.55% |
| 5 | IOVA | Iovance Biotherapeutics | 2.51% |
| 6 | KNSA | Kiniksa Pharmaceuticals International | 2.46% |
| 7 | ADMA | ADMA Biologics | 2.23% |
| 8 | REGN | Regeneron Pharmaceuticals | 2.11% |
| 9 | BGNE | BeOne Medicines | 2.11% |
| 10 | HALO | Halozyme Therapeutics | 1.88% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 20, 2017 | Dec 27, 2017 | $0.0723 |
| Dec 21, 2015 | Dec 29, 2015 | $0.40 |